Niethammer et al. showed that oral DNA vaccine encoding full-length VEGFR-2 effectively protected mice from lethal challenge with melanoma, colon carcinoma, lung carcinoma cells and reduced metastases in therapeutic model14. This evidence concerns the gene KDR and colon carcinoma.